FGPHF (FGPHF) Stock Price & Analysis
FGPHF (FGPHF) fell 3.64% to USD 0.05 as of June 10, 2026 at 09:02 UTC, according to Nexqual real-time market data.
FGPHF last closed at USD 0.05; the session ranged USD 0.05–0.05 on volume of 24,782 shares. Market capitalization is $39.63M, with a 52-week range of USD 0–0.13 (OQB). Source: Nexqual, June 10, 2026 at 09:02 UTC.
Key Statistics (as of June 10, 2026 at 09:02 UTC)
| Price | USD 0.05 |
|---|---|
| Change | ▼ 3.64% (down) |
| Previous Close | USD 0.05 |
| Open | USD 0.05 |
| Day Range | USD 0.05 – 0.05 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 24,782 shares |
| Market Cap | $39.63M |
| Exchange | OQB |
Technical Analysis (FGPHF)
Nexqual's technical model rates FGPHF "NEUTRAL" based on 2 bullish and 3 bearish signals across 123 daily candles, as of June 10, 2026 at 09:02 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.68 (neutral) |
| vs SMA50 | Below (USD 0.05) |
| MACD | -0 (negative) |
Analyst Ratings (FGPHF)
Wall Street analysts rate FGPHF "None", per Nexqual as of June 10, 2026 at 09:02 UTC.
| Consensus Rating | None |
|---|
Earnings (FGPHF)
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financials & Fundamentals (FGPHF)
| Total Revenue | $576,616 |
|---|---|
| Revenue Growth (YoY) | +52.60% |
| Gross Margin | +30.36% |
| Operating Margin | -517.88% |
| Profit Margin | +0.00% |
| ROE | -96.23% |
| Debt / Equity | 4.83 |
| Current Ratio | 7.56 |
| Total Cash | $4.90M |
| Total Debt | $425,923 |
| Free Cash Flow | $-593,598 |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Financial Health Score (FGPHF)
Nexqual rates FGPHF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 09:02 UTC.
| Growth | Strong — Revenue +53% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $5M cash, no debt |
| Cash Flow | Weak — FCF negative: -$594K, burning cash |
| Efficiency | Critical — ROE -96%, ROA -24.5% |
Ownership (FGPHF)
| Insider Ownership | +20.71% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 880.69M |
| Float | 743.59M |
Source: Nexqual, June 10, 2026 at 09:02 UTC.
Leadership (FGPHF)
FGPHF is led by Michael Bell, MD, CEO & Director, per Nexqual as of June 10, 2026 at 09:02 UTC.
| MD, CEO & Director | Michael Bell |
|---|---|
| Senior Scientific Advisor & Non Executive Director | Andrew Goodwin |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HDGHF | HAYDALE PLC | USD 0 | ▼ 25% |
| NNXPF | Nanoxplore Inc. | USD 1.26 | ▼ 3.82% |
| VRSRF | Versarien Plc | USD 0 | ▲ 0% |
| GMGMF | Graphene Manufacturing Group Lt | USD 1.69 | ▼ 3.43% |
| GPHBF | G6 Materials Corp. | USD 0 | ▼ 50% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:02 UTC. This page is informational and not investment advice.